PDE5 inhibitors - PDFSEARCH.IO - Document Search Engine

PDE5 inhibitors
Results: 177

#	Item
141	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use REVATIO safely and effectively. See full prescribing information for REVATIO. REVATIO (sildenafil) tablets, for oral Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-03-21 13:39:52 PDE5 inhibitors Pfizer Piperazines Pyrazolopyrimidines Sildenafil Oxazepam CGMP-specific phosphodiesterase type 5 Pulmonary hypertension Tadalafil Chemistry Organic chemistry Lactams
142	Sanofi and Lilly announce licensing agreement for Cialis® (tadalafil) OTC - Companies anticipate providing over-the-counter (OTC) product to treat erectile dysfunction after expiration of certain patents PARIS, France, Add to Reading List Source URL: en.sanofi.com Language: English - Date: 2014-05-28 00:01:30 Organic chemistry Chemistry Eli Lilly and Company Tadalafil Piperazines Pharmaceuticals policy Sildenafil Erectile dysfunction Finasteride Lactams Human sexuality PDE5 inhibitors
143	Consumer Health Information www.fda.gov/consumer/update/erectiledysfunction010408.html www.fda.gov/consumer Add to Reading List Source URL: www.fda.gov Language: English Medicine PDE5 inhibitors Piperazines Pyrazolopyrimidines United States Public Health Service Sildenafil Dietary supplement FDA Consumer Erectile dysfunction Chemistry Organic chemistry Food and Drug Administration
144	Erectile Dysfunction - Your Choices Introduction Impotence is a common condition. A man who is impotent is persistently unable to achieve or maintain an erection for satisfactory sexual intercourse. Add to Reading List Source URL: www.nlm.nih.gov Language: English - Date: 2014-04-30 11:18:25 Lactams PDE5 inhibitors Sexual arousal Sexual health Piperazines Erectile dysfunction Erection Sildenafil Priapism Reproductive system Human sexuality Medicine
145	Enhance_nutraceutical_OUDLC_Cyber_Letter__final_[1].doc Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Lactams PDE5 inhibitors Diabetes Medical terms Erectile dysfunction Food and Drug Administration Tadalafil Prostate cancer Medicine Health Human sexuality
146	Amrutam_life_care_OUDLC_cyber_letter__final_[1].doc Add to Reading List Source URL: www.fda.gov Language: English Pharmaceutical sciences Pharmacology Pharmaceuticals policy PDE5 inhibitors Food law Federal Food Drug and Cosmetic Act Sildenafil New Drug Application Erectile dysfunction Medicine Health Food and Drug Administration
147	DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Rockville, MD 20857 Add to Reading List Source URL: www.fda.gov Language: English PDE5 inhibitors Lactams Piperazines Schering-Plough Sulfones Vardenafil CGMP-specific phosphodiesterase type 5 Erectile dysfunction Bayer Chemistry Human sexuality Organic chemistry
148	M:mithters's Healthgra Viagra DTC[removed]doc Add to Reading List Source URL: www.fda.gov Language: English Lactams Health Pfizer Piperazines Pyrazolopyrimidines Sildenafil Erectile dysfunction Adverse effect Herbal viagra Medicine PDE5 inhibitors Organic chemistry
149	MEDICATION GUIDE Adempas (a dem pahs) (riociguat) Add to Reading List Source URL: www.fda.gov Language: English Eli Lilly and Company Lactams PDE5 inhibitors Menstrual cycle Amines Menopause Tadalafil Methadone Pregnancy Chemistry Organic chemistry Medicine
150	Australian Public Assessment Report for Tadalafil Add to Reading List Source URL: www.tga.gov.au Language: English - Date: 2013-12-04 21:21:29 PDE5 inhibitors Eli Lilly and Company Tadalafil CGMP-specific phosphodiesterase type 5 Sildenafil Pulmonary hypertension Erectile dysfunction Vasodilation Sitaxentan Chemistry Organic chemistry Lactams